Biblio

Export 4 results:
Author Title [ Type(Desc)] Year
Filters: Author is Riedel, Gernot  [Clear All Filters]
Journal Article
H. Shiells, Schelter, B. O., Bentham, P., Baddeley, T. C., Rubino, C. M., Ganesan, H., Hammel, J., Vuksanovic, V., Staff, R. T., Murray, A. D., Bracoud, L., Wischik, D. J., Riedel, G., Gauthier, S., Jia, J., Moebius, H. J., Hardlund, J., Kipps, C. M., Kook, K., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., “Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 75, no. 2, pp. 501-519, 2020.
K. Plucińska, Crouch, B., Yeap, J. M., Stoppelkamp, S., Riedel, G., and Platt, B., “Histological and Behavioral Phenotypes of a Novel Mutated APP Knock-In Mouse.”, J Alzheimers Dis, vol. 65, no. 1, pp. 165-180, 2018.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., “Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
A. Sil, Erfani, A., Lamb, N., Copland, R., Riedel, G., and Platt, B., “Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model.”, J Alzheimers Dis, vol. 85, no. 2, pp. 755-778, 2022.